Results 51 to 60 of about 4,944 (197)

Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation

EMBO Molecular Medicine, 2021
Hormonal contraception exposes women to synthetic progesterone receptor (PR) agonists, progestins, and transiently increases breast cancer risk. How progesterone and progestins affect the breast epithelium is poorly understood because we lack adequate ...
Marie Shamseddin, Fabio De Martino, Céline Constantin, Valentina Scabia, Anne‐Sophie Lancelot, Csaba Laszlo, Ayyakkannu Ayyannan, Laura Battista, Wassim Raffoul, Marie‐Christine Gailloud‐Matthieu, Philipp Bucher, Maryse Fiche, Giovanna Ambrosini, George Sflomos, Cathrin Brisken   +14 more
doaj   +1 more source

Cross‐sectional and longitudinal metabolomics‐based profiles associated with oral contraceptive and progestin‐only pill use: A Finnish population‐based study

Acta Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 9, Page 1640-1651, September 2025.
In a metabolomics study of over 200 metabolites in 1721 fertile‐aged women, we found that current use of combined oral contraceptives (COC), especially third‐generation and other COCs, is associated with altered levels of several metabolic measures compared to nonuse of hormonal contraception or to use of a levonorgestrel intrauterine device (LNG‐IUD).
Elena Toffol, Jari Haukka, Pekka Jousilahti, Lara Lehtoranta, Anni Joensuu, Timo Partonen, Iris Erlund, Oskari Heikinheimo   +7 more
wiley   +1 more source

Actualización en anticoncepción hormonal [PDF]

, 2011
La anticoncepción hormonal constituye el segundo método anticonceptivo más utilizado en nuestro país. Las principales novedades en cuanto a composición son la introducción del valerato de estradiol como componente estrogénico para mejorar la seguridad ...
Cuesta Benjumea, R. de la, Franco Tejeda, Cristina, Iglesias Goy, Enrique   +2 more
core   +1 more source

Evaluation of coagulation activation after Rhinovirus infection in patients with asthma and healthy control subjects: an observational study [PDF]

, 2014
Background Asthma exacerbations are frequently triggered by rhinovirus infections. Both asthma and respiratory tract infection can activate haemostasis. Therefore we hypothesized that experimental rhinovirus-16 infection and asthmatic airway inflammation
Bel, EHD, De Pol, MAV, Johnston, SL, Kamphuisen, PW, Lutter, R, Majoor, CJ, Meijers, JCM, Molenkamp, R, Nieuwland, R, Sterk, PJ, Van der Poll, T, Van der Sluijs, KF, Wolthers, KC   +12 more
core   +4 more sources

EudraVigilance insights: Suspected adverse drug reactions in infants through breastfeeding

British Journal of Clinical Pharmacology, Volume 91, Issue 8, Page 2431-2436, August 2025.
Aims We aimed to describe suspected adverse drug reactions (ADRs) in infants resulting from medications transmitted through mothers' milk, as reported to the European ADR database, EudraVigilance. The research sought to understand the frequency, seriousness and nature of these ADRs to assess potential risks associated with maternal medication use ...
Ida M. Heerfordt, Ditte Resendal Gotfredsen, Henrik Horwitz, Anette Kirstine Stark, Jon Trærup Andersen, Christina Gade, Ulrik Lausten‐Thomsen, Rasmus Huan Olsen   +7 more
wiley   +1 more source

Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial

BMC Research Notes, 2023
Objective To evaluate if daily oral 75 µg of Desogestrel (DSG) for 3 months prior to the insertion of etonogestrel-releasing contraceptive implant (ENG-IMPLANT) might help reduce its premature discontinuation.
Valeria Lombardi Fäh, Rosa Catarino, Sarah Castillo, Maria Badda, Sibel Gezer-Dickschat, Friederike Thieringer, Sibil Tschudin, Manuela Viviano, Michal Yaron   +8 more
doaj   +1 more source

Hormonal contraception with desogestrel-induced medication use [PDF]

Гинекология, 2014
This article presents current information on existing methods hormonal contraception, covered medical and clinical aspects acceptability of hormonal contraceptives.An important emphasis is made on the benefits of Laktinet® in women of postpartum period ...
S A Levakov, N A Sheshukova
doaj  

The effectiveness of desogestrel for endometrial protection in women with abnormal uterine bleeding-ovulatory dysfunction: a non-inferiority randomized controlled trial

Scientific Reports, 2022
Women with chronic abnormal uterine bleeding-ovulatory dysfunction (AUB-O) are at increased risk of endometrial neoplasia. We conducted a non-inferiority randomized controlled trial to determine the effectiveness of two cyclic-progestin regimens orally ...
Nisarath Soontrapa, Manee Rattanachaiyanont, Malee Warnnissorn, Thanyarat Wongwananuruk, Suchada Indhavivadhana, Prasong Tanmahasamut, Kitirat Techatraisak, Surasak Angsuwathana   +7 more
doaj   +1 more source

a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC) [PDF]

, 2017
Several data indicate that migraine, especially migraine with aura, is associated with an increased risk of ischemic stroke and other vascular events. Of concern is whether the risk of ischemic stroke in migraineurs is magnified by the use of hormonal ...
Aegidius, Karen Lehrmann, Bitzer, Johannes, Canonico, Marianne, Kurth, Tobias, Merki-Feld, Gabriele S., Sacco, Simona   +5 more
core   +1 more source

Which combined oral contraceptives to prescribe with cardiovascular safety in mind? [PDF]

, 2017
When prescribing combined oral contraceptives, choose one containing levonorgestrel and low-dose estrogen (20 mcg) to minimize the risks of pulmonary embolism, ischemic stroke, and myocardial ...
Coe, Catherine, Lam, Yee, Mounsey, Anne, Prasad, Shailendra   +3 more
core